DRTS · Alpha Tau Medical Ltd.
$12.99
-0.27 (-2.04%)
At close · Aug 6
Market Cap
$1.17B
Shares
90.33M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$12.99
Open$13.31
Day$12.80–13.55
52W$3.00–14.11
Avg vol 30d748K
Short int3.0M · 3.3% float · 3.7d
Short vol42%
Last earningsMay 11, 2026
DataMar 2021–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+69%
above
Price vs 50-day avg
+14%
above
RSI (14)
57
neutral
MACD trend
Negative
52-week position
90%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+80%
trailing
YTD return
+162%
this year
Relative strength
+67%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $8 — 50d above 200d
Institutional flow
Accumulating
28 of 53 funds reported for Jun 30 · net +1.0M sh shares · +13 new
Insider flow
Distributing
Net -$352.1K over 90 days · 100% sells
Short interest
Rising
3.30% of float · ▲ +35.1% MoM · 3.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
53 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
EPS growth
−18%
Y/Y
Free cash flow
$-32.8M
Balance sheet
$7.0M
net cash
Quant / Vol
risk profile
Volatility
79%
annualized · 1-yr
Max drawdown
−24%
past year
ATR
6.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+69%
Bullish
Price vs 50-day avg
+14%
Bullish
RSI (14)
57
Neutral
MACD trend
Negative
Bearish
52-week position
90%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $11 › 200d $8 — 50d above 200d
Institutional flow
Accumulating
28 of 53 funds reported for Jun 30 · net +1.0M sh shares · +13 new
Insider flow
Distributing
Net -$352.1K over 90 days · 100% sells
Short interest
Rising
3.30% of float · ▲ +35.1% MoM · 3.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
53 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $3
Now $13 · 90%
52-wk high $14
vs 200-day avg +69%
vs 50-day avg +14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DRTS
this stock
Alpha Tau Medical Ltd.
|
$1.17B | +162.4% | — | — | 3.3% |
|
ONC
BeOne Medicines Ltd.
|
$487.49B | +8.6% | +22179.2% | 749.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$122.68B | +6.8% | +46.2% | 28.2 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$79.49B | +0.3% | +20.8% | 19.1 | 3.4% |
|
ARGX
Argenx SE
|
$54.76B | +4.1% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DRTS | +9.3% | +0.1% | +79.7% | +10.2% | +162.4% |
| SPY | +3.6% | +2.2% | +12.8% | +2.9% | +12.7% |
| vs SPY | +5.6% | -2.2% | +66.9% | +7.3% | +149.7% |
Key facts
CIK
1871321
CUSIP
M0740A108
13F (30d)
27 filings
27 filers
Visit website
Investor relations